Lobe-Specific Heterogeneity and Matrix Metalloproteinase Activation after Ischemia/Reperfusion Injury in Rat Livers

Toxicologic Pathology

Volumn 40, Issue 5, 2012, Pages 722-730

  Palladini, Giuseppina ^a   Ferrigno, Andrea ^a   Rizzo, Vittoria ^a   Boncompagni, Eleonora ^a   Richelmi, Plinio ^a   Freitas, Isabel ^a   Perlini, Stefano ^a   Vairetti, Mariapia ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

ischemia reperfusion; liver lobe heterogeneity; MDA; MMPs TNF apha; MPO

Indexed keywords

GELATINASE A; GELATINASE B; MALONALDEHYDE; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CELL VACUOLE; CONTROLLED STUDY; CYTOPLASM; EDEMA; ENZYME ACTIVATION; ENZYME ACTIVITY; LIVER BIOPSY; LIVER HISTOLOGY; LIVER INJURY; LIVER PARENCHYMA; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANIMALS; EXTRACELLULAR MATRIX; ISCHEMIA; LIVER; MALE; MALONDIALDEHYDE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PEROXIDASE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84862737862     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623312441403     Document Type: Article

References (45)

1. Amanzada A. Malik I. A. Nischwitz M. Sultan S. Naz N. Ramadori G. (2011). Myeloperoxidase and elastase are only expressed by neutrophils in normal and in inflamed liver. Histochem Cell Biol 135, 305–15.
2. Atkinson J. J. Senior R. M. (2003). Matrix metalloproteinase-9 in lung remodeling. Am J Respir Cell Mol Biol 28, 12–24.
3. A.A.M., Coelho, M.M.C., Machado, H.K., Takahashi, S.N., Sampietre, J.T., Stefano, A.A.A., Leite, R., Curi, L.L.C., D’Albuquerque, Ischemic preconditioning-like effect of polyunsaturated fatty acid-rich diet on hepatic ischemia/reperfusion injury, J Gastrointest Surg, (2011), 15, 1679-1688
4. L.M., Colletti, D.G., Remick, G.D., Burtch, S.L., Kunkel, R.M., Strieter, D.D.J., Campbell, Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat, J Clin Invest, (1990), 85, 1936-1943
5. Cursio R. Mari B. Louis K. Rostagno P. Saint-Paul M. Giudicelli J. Bottero V. Anglard P. Yiotakis A. Dive V. Gugenheim J. Auberger P. (2002). Rat liver injury after normothermic ischemia is prevented by a phosphinic matrix metalloproteinase inhibitor. FASEB J 16, 93–5.
6. Deleve L. D. Wang X. Tsai J. Kanel G. Strasberg S. Tokes Z. A. (2003). Sinusoidal obstruction syndrome (veno-occlusive disease) in the rat is prevented by matrix metalloproteinase inhibition. Gastroenterology 125, 882–90.
7. Duchen L. W. (1961). The effects of deprivation of portal blood on the liver and its influence on carbon tetrachloride liver injury in the rat. Br J Exp Pathol 42, 247–52.
8. Duenschede F. Westermann S. Miesner I. Albrecht-Schöck S. Kneist W. Korenkov M. Schad A. Dutkowski P. Kiemer A. K. Junginger T. (2007). Hepatocellular injury of nonischemic liver tissue after selective clamping in rats—protective action by pharmacological pretreatment with lipoic acid. Eur Surg Res 39, 325–31.
9. Faa G. Nurchi V. Demelia L. Ambu R. Parodo G. Congiu T. Sciot R. Van Eyken P. Silvagni R. Crisponi G. (1995). Uneven hepatic copper distribution in Wilson’s disease. J Hepatol 22, 303–8.
10. Garcia-Moreno L. Vallejo G. Arias J. L. Aller M. A. Lorente L. Arias J. (1994). Behaviour of nucleolar organizer regions in the different Wistar rat liver lobes. Lab Anim 28, 50–4.
11. Hamada T. Fondevila C. Busuttil R. W. Coito A. J. (2008). Metalloproteinase-9 deficiency protects against hepatic ischemia/reperfusion injury. Hepatology 47, 186–98.
12. Helling T. S. Hacker K. A. Kragel P. J. Eisenstein C. L. (1994). Evidence for cytoprotection by prostaglandin E1 with normothermic hepatic ischemia. J Surg Res 56, 309–13.
13. Hsu C. Wang J. Liu C. Chen L. (2002). Kupffer cells protect liver from ischemia-reperfusion injury by an inducible nitric oxide synthase-dependent mechanism. Shock 17, 280–5.
14. Irwin R. D. Parker J. S. Lobenhofer E. K. Burka L. T. Blackshear P. E. Vallant M. K. Lebetkin E. H. Gerken D. F. Boorman G. A. (2005). Transcriptional profiling of the left and median liver lobes of male f344/n rats following exposure to acetaminophen. Toxicol Pathol 33, 111–7.
15. Jaeschke H. Farhood A. Smith C. W. (1990). Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo. FASEB J 4, 3355–9.
16. Khandoga A. Kessler J. S. Hanschen M. Khandoga A. G. Burggraf D. Reichel C. Hamann G. F. Enders G. Krombach F. (2006). Matrix metalloproteinase-9 promotes neutrophil and T cell recruitment and migration in the postischemic liver. J Leukoc Biol 79, 1295–305.
17. Kleiner D. E. Stetler-Stevenson W. G. (1994). Quantitative zymography: Detection of picogram quantities of gelatinases. Anal Biochem 218, 325–9.
18. Knittel T. Mehde M. Kobold D. Saile B. Dinter C. Ramadori G. (1999). Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: Regulation by TNF-alpha and TGF-beta1. J Hepatol 30, 48–60.
19. Koda M. Bauer M. Krebs A. Hahn E. G. Schuppan D. Murawaki Y. (2006). Endothelin-1 enhances fibrogenic gene expression, but does not promote DNA synthesis or apoptosis in hepatic stellate cells. Comp Hepatol 5, 5.
20. Kossakowska A. E. Edwards D. R. Lee S. S. Urbanski L. S. Stabbler A. L. Zhang C. L. Phillips B. W. Zhang Y. Urbanski S. J. (1998). Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis. Am J Pathol 153, 1895–902.
21. Kuebler W. M. Abels C. Schuerer L. Goetz A. E. (1996). Measurement of neutrophil content in brain and lung tissue by a modified myeloperoxidase assay. Int J Microcirc Clin Exp 16, 89–97.
22. J.P., Kuyvenhoven, J., Ringers, H.W., Verspaget, C.C.H.W., Lamers, B., van Hoek, Serum matrix metalloproteinase MMP-2 and MMP-9 in the late phase of ischemia and reperfusion injury in human orthotopic liver transplantation, Transplant Proc, (2003), 35, 2967-2969
23. J.P., Kuyvenhoven, H.W., Verspaget, Q., Gao, J., Ringers, V.V.H.B.M., Smit, C.C.H.W., Lamers, B., van Hoek, Assessment of serum matrix metalloproteinases MMP-2 and MMP-9 after human liver transplantation: Increased serum MMP-9 level in acute rejection, Transplantation, (2004), 77, 1646-1652
24. Lawson T. A. Pound A. W. (1974). The different susceptibility of rat liver lobes to carbon tetrachloride and dimethylnitrosamine. Br J Exp Pathol 55, 583–8.
25. Lentsch A. B. Yoshidome H. Cheadle W. G. Miller F. N. Edwards M. J. (1998). Chemokine involvement in hepatic ischemia/reperfusion injury in mice: Roles for macrophage inflammatory protein-2 and KC. Hepatology 27, 1172–7.
26. Leroy V. Monier F. Bottari S. Trocme C. Sturm N. Hilleret M. Morel F. Zarski J. (2004). Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: Comparison with PIIINP and hyaluronic acid. Am J Gastroenterol 99, 271–9.
27. Lowry O. H. Rosebrough N. J. Farr A. L. Randall R. J. (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193, 265–75.
28. Ma Z. Y. Qian J. M. Rui X. H. Wang F. R. Wang Q. W. Cui Y. Y. Peng Z. H. (2010). Inhibition of matrix metalloproteinase-9 attenuates acute small-for-size liver graft injury in rats. Am J Transplant 10, 784–95.
29. Malarkey D. E. Johnson K. Ryan L. Boorman G. Maronpot R. R. (2005). New insights into functional aspects of liver morphology. Toxicol Pathol 33, 27–34.
30. Matsui N. Kasajima K. Hada M. Nagata T. Senga N. Yasui Y. Fukuishi N. Akagi M. (2005). Inhibition of NF-kappaB activation during ischemia reduces hepatic ischemia/reperfusion injury in rats. J Toxicol Sci 30, 103–10.
31. L.L.C., Miranda, V.K., Capellini, G.S., Reis, A.C., Celotto, C.C.J., Carlotti, P.P.B., Evora, Effects of partial liver ischemia followed by global liver reperfusion on the remote tissue expression of nitric oxide synthase: Lungs and kidneys, Transplant Proc, (2010), 42, 1557-1562
32. Moore C. Shen X. Gao F. Busuttil R. W. Coito A. J. (2007). Fibronectin-alpha4beta1 integrin interactions regulate metalloproteinase-9 expression in steatotic liver ischemia and reperfusion injury. Am J Pathol 170, 567–77.
33. Ram M. Sherer Y. Shoenfeld Y. (2006). Matrix metalloproteinase-9 and autoimmune diseases. J Clin Immunol 26, 299–307.
34. Regev A. Berho M. Jeffers L. J. Milikowski C. Molina E. G. Pyrsopoulos N. T. Feng Z. Reddy K. R. Schiff E. R. (2002). Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 97, 2614–8.
35. Richardson F. C. Boucheron J. A. Dyroff M. C. Popp J. A. Swenberg J. A. (1986). Biochemical and morphologic studies of heterogeneous lobe responses in hepatocarcinogenesis. Carcinogenesis 7, 247–51.
36. Ruepp S. U. Tonge R. P. Shaw J. Wallis N. Pognan F. (2002). Genomics and proteomics analysis of acetaminophen toxicity in mouse liver. Toxicol Sci 65, 135–50.
37. Serafín A. Roselló-Catafau J. Prats N. Gelpí E. Rodés J. Peralta C. (2004). Ischemic preconditioning affects interleukin release in fatty livers of rats undergoing ischemia/reperfusion. Hepatology 39, 688–98.
38. Singh R. Leuratti C. Josyula S. Sipowicz M. A. Diwan B. A. Kasprzak K. S. Schut H. A. Marnett L. J. Anderson L. M. Shuker D. E. (2001). Lobe-specific increases in malondialdehyde DNA adduct formation in the livers of mice following infection with Helicobacter hepaticus. Carcinogenesis 22, 1281–7.
39. Teutsch H. F. Schuerfeld D. Groezinger E. (1999). Three-dimensional reconstruction of parenchymal units in the liver of the rat. Hepatology 29, 494–505.
40. Tozzi R. Palladini G. Fallarini S. Nano R. Gatti C. Presotto C. Schiavone A. Micheletti R. Ferrari P. Fogari R. Perlini S. (2007). Matrix metalloprotease activity is enhanced in the compensated but not in the decompensated phase of pressure overload hypertrophy. Am J Hypertens 20, 663–9.
41. Uehara T. Murai T. Inoue S. Maruyama T. Touchi A. Mori S. Matsubara T. (2004). Heterogeneous liver lobe responses of carbon tetrachloride-induced hepatotoxicity in male rats pretreated with hepatic enzyme-inducing agents. J Toxicol Pathol 17, 223–30.
42. Uemura T. Miyazaki M. Hirai R. Matsumoto H. Ota T. Ohashi R. Shimizu N. Tsuji T. Inoue Y. Namba M. (2000). Different expression of positive and negative regulators of hepatocyte growth in growing and shrinking hepatic lobes after portal vein branch ligation in rats. Int J Mol Med 5, 173–9.
43. Visse R. Nagase H. (2003). Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 92, 827–39.
44. Wang W. Yen H. Chen C. Jasani N. Soni R. Koscica K. Reznik S. E. (2010). Prevention of inflammation-associated preterm birth by knockdown of the endothelin-1-matrix metalloproteinase-1 pathway. Mol Med 16, 505–12.
45. Yokoyama Y. Baveja R. Sonin N. Nakanishi K. Zhang J. X. Clemens M. G. (2000). Altered endothelin receptor subtype expression in hepatic injury after ischemia/reperfusion. Shock 13, 72–8.